Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyReferences
- Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).Am J Cardiol. 2005; 96: 1374-1378
- The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease.J Vasc Surg. 2007; 45: 47-54
- Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.J Vasc Surg. 2006; 43: 772-780
- Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis.Radiology. 2002; 225: 21-26
- Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.Arterioscler Thromb Vasc Biol. 1997; 17: 3208-3214
- Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.J Endovasc Ther. 2001; 8: 477-483
- Endovascular revascularization below the knee: 6-month results and the predictive value of C-reactive protein level.Radiology. 2003; 227: 419-425
- Exercise training reduces the acute inflammatory response associated with claudication.Eur J Vasc Endovasc Surg. 2002; 23: 309-316
- The ankle brachial index as a measure of leg functioning and physical activity in peripheral arterial disease: the Walking And Leg Circulation Study.Ann Intern Med. 2002; 136: 873-883
- Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms.JAMA. 2004; 292: 453-461
- Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.J Am Geriatr Soc. 2001; 49: 747-754
- Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular disease.J Am Coll Cardiol. 2004; 44: 618-623
- Effect of diagnostic criteria on the prevalence of peripheral arterial disease.Circulation. 1995; 91: 1472-1479
- Enzymatic determination of total serum cholesterol.Clin Chem. 1974; 20: 470-475
- Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated a-cyclodextrin.Clin Chem. 1995; 41: 717-723
- The Women's Health and Aging Study: Health and Social Characteristics of Older Women With Disability.National Institute on Aging, Bethesda, MD1995
- Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: The InCHIANTI Study.J Am Geriatr Soc. 2004; 52: 405-410
- Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.J Appl Physiol. 1998; 86: 1097-1098
- The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing.Vasc Med. 1996; 1: 65-71
- Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease.J Am Geriatr Soc. 2007; 55: 400-406
- Mortality over a period of 10 years in patients with peripheral arterial disease.N Engl J Med. 1992; 326: 381-386
- Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.JAMA. 1993; 270: 487-489
- Physical activity during daily life and mortality in patients with peripheral arterial disease.Circulation. 2006; 114: 242-248
- Elevated levels of inflammation, D-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease.J Am Coll Cardiol. 2007; 50: 897-905
Article info
Publication history
Footnotes
This study was supported by Grants R01-HL58099, R01-HL64739, R01-HL71223, and R01-HL076298 from the National Heart Lung and Blood Institute, Bethesda, Maryland; by Grant RR-00048 from the National Center for Research Resources, National Institutes of Health, Bethesda, Maryland; and in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health.